Ying Hong Jiang

age ~40

from Staten Island, NY

Get Report

Also known as:

Connected to:

Ying Jiang Phones & Addresses

view source

Licenses:

New York - Currently registered 2012

Education:

Washington University IN St. Louis

view source

Author
Ying Jiang

ISBN #
7507518205

G-Protein Coupled Receptor Ligands And Methods
view source
US Patent:

7338772, Mar 4, 2008
Filed:

Apr 10, 2003
Appl. No.:

10/411545
Inventors:

Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:

Schering Corporation - Kenilworth NJ
International Classification:

G01N 33/566
US Classification:

435 721, 435 72, 436501
Abstract:

The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

G-Protein Coupled Receptor Ligands And Methods
view source
US Patent:

7807390, Oct 5, 2010
Filed:

Jan 7, 2008
Appl. No.:

11/970276
Inventors:

Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:

Schering Corporation - Kenilworth NJ
International Classification:

G01N 33/566
C07K 14/705
US Classification:

435 721, 435 71, 435 72, 436501
Abstract:

The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

Antibodies And Functional Fragments Thereof That Specifically Bind An Rf-Amide Peptide Or A Precursor Thereof
view source
US Patent:

8133980, Mar 13, 2012
Filed:

Oct 1, 2010
Appl. No.:

12/896297
Inventors:

Ying Jiang - Scotch Plains NJ, US
Fang Liang Zhang - Fanwood NJ, US
Nicholas J. Murgolo - Millington NJ, US
Lin Luo - Edison NJ, US
Jason S. Simon - Westfield NJ, US
Assignee:

Schering Corporation - Kenilworth NJ
International Classification:

C07K 16/00
C12P 21/08
US Classification:

5303879, 5303881, 53038815, 4241391
Abstract:

The present invention relates to RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate the receptor.

Cell-Based High-Throughput Screening Methods
view source
US Patent:

20040253647, Dec 16, 2004
Filed:

Aug 6, 2004
Appl. No.:

10/481954
Inventors:

Paul Mathews - Irvington-on-Hudson NY, US
Ralph Nixon - Tarrytown NY, US
Stephen Schmidt - Nutley NJ, US
Ying Jiang - Valhalla NY, US
International Classification:

G01N033/53
G01N033/567
US Classification:

435/007200
Abstract:

The present invention describes cell-based screening methods that allow for the elimination of false-positive results due to nonspecific toxicity of test compounds, while detecting those compounds that specifically modulate cellular metabolites in metabolic pathways associated with diseases and disorders, with particular regard to Alzheimer's disease. The methods are particularly suited to high-throughput screening techniques to identify compounds (drugs) that are effective in a cell-based system. The methods of the invention involve determining within a cell system the levels of both a metabolic precursor and a metabolite of interest and have broad application in high-throughput drug discovery and identification, particularly for precursor and metabolite molecules which are associated with disease and disease progression, such as Alzheimer's disease.